Desmoplastic melanoma: a brief review and the efficacy of immunotherapy

Cesar E. Ochoa, Richard W Joseph

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)205-207
Number of pages3
JournalExpert Review of Anticancer Therapy
Volume19
Issue number3
DOIs
StatePublished - Mar 4 2019

Fingerprint

Renal Cell Carcinoma
Immunotherapy
Melanoma
nivolumab

Keywords

  • Checkpoint inhibitors
  • immunotherapy
  • nivolumab
  • renal cell carcinoma
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Desmoplastic melanoma : a brief review and the efficacy of immunotherapy. / Ochoa, Cesar E.; Joseph, Richard W.

In: Expert Review of Anticancer Therapy, Vol. 19, No. 3, 04.03.2019, p. 205-207.

Research output: Contribution to journalEditorial

@article{cd5c1b2889ee459f916019c2b4c89a26,
title = "Desmoplastic melanoma: a brief review and the efficacy of immunotherapy",
keywords = "Checkpoint inhibitors, immunotherapy, nivolumab, renal cell carcinoma, targeted therapy",
author = "Ochoa, {Cesar E.} and Joseph, {Richard W}",
year = "2019",
month = "3",
day = "4",
doi = "10.1080/14737140.2019.1574573",
language = "English (US)",
volume = "19",
pages = "205--207",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Desmoplastic melanoma

T2 - a brief review and the efficacy of immunotherapy

AU - Ochoa, Cesar E.

AU - Joseph, Richard W

PY - 2019/3/4

Y1 - 2019/3/4

KW - Checkpoint inhibitors

KW - immunotherapy

KW - nivolumab

KW - renal cell carcinoma

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85061053908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061053908&partnerID=8YFLogxK

U2 - 10.1080/14737140.2019.1574573

DO - 10.1080/14737140.2019.1574573

M3 - Editorial

C2 - 30686076

AN - SCOPUS:85061053908

VL - 19

SP - 205

EP - 207

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 3

ER -